Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific demethylase 4A | Starlite/ChEMBL | No references |
Homo sapiens | chromobox homolog 1 | Starlite/ChEMBL | No references |
Homo sapiens | bromodomain adjacent to zinc finger domain, 2B | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | peregrin | 0.0038 | 0.1455 | 0.1231 |
Echinococcus granulosus | lysine specific demethylase 5A | 0.0045 | 0.2213 | 0.2009 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.1334 | 0.1993 |
Schistosoma mansoni | bromodomain containing protein | 0.0076 | 0.5698 | 0.7722 |
Onchocerca volvulus | 0.0037 | 0.1334 | 0.1137 | |
Schistosoma mansoni | chromobox protein | 0.0084 | 0.6551 | 0.8879 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0043 | 0.2044 | 0.1835 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0.1138 | 0.5 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0045 | 0.2213 | 0.3307 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0027 | 0.0255 | 0.0346 |
Loa Loa (eye worm) | hypothetical protein | 0.0085 | 0.6692 | 1 |
Brugia malayi | PHD-finger family protein | 0.0035 | 0.1138 | 0.0601 |
Brugia malayi | chromobox protein homolog 3 | 0.0047 | 0.2461 | 0.2004 |
Loa Loa (eye worm) | hypothetical protein | 0.0047 | 0.2461 | 0.3678 |
Echinococcus multilocularis | jumonji domain containing protein | 0.0049 | 0.2664 | 0.2472 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0051 | 0.2857 | 1 |
Schistosoma mansoni | jumonji domain containing protein | 0.0092 | 0.7378 | 1 |
Schistosoma mansoni | chromobox protein | 0.0084 | 0.6551 | 0.8879 |
Echinococcus granulosus | Transcription factor JmjC domain containing protein | 0.0115 | 1 | 1 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0072 | 0.5219 | 0.5094 |
Loa Loa (eye worm) | heterochromatin protein 1 | 0.0084 | 0.6551 | 0.979 |
Brugia malayi | Bromodomain containing protein | 0.0091 | 0.7263 | 0.7097 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 0.6551 | 0.6461 |
Toxoplasma gondii | PHD-finger domain-containing protein | 0.0035 | 0.1138 | 0.5 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0045 | 0.2213 | 0.2999 |
Echinococcus granulosus | jumonji domain containing protein | 0.0049 | 0.2664 | 0.2472 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0043 | 0.2044 | 0.1835 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 0.6551 | 0.6461 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.2941 | 0.4395 |
Echinococcus multilocularis | PHD finger protein rhinoceros | 0.0035 | 0.1138 | 0.0906 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.1138 | 0.1701 |
Loa Loa (eye worm) | hypothetical protein | 0.0046 | 0.237 | 0.3541 |
Giardia lamblia | PHD finger protein 15 | 0.0035 | 0.1138 | 0.5 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.2857 | 0.3419 |
Echinococcus granulosus | peregrin | 0.0038 | 0.1455 | 0.1231 |
Loa Loa (eye worm) | jmjC domain-containing protein | 0.0073 | 0.5286 | 0.7899 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.3921 | 0.5859 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.2461 | 0.2714 |
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.1138 | 0.5 |
Schistosoma mansoni | bromodomain-containing nuclear protein 1 brd1 | 0.0035 | 0.1138 | 0.1543 |
Brugia malayi | Heterochromatin protein 1 | 0.0084 | 0.6551 | 0.6342 |
Echinococcus granulosus | PHD finger protein rhinoceros | 0.0035 | 0.1138 | 0.0906 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0072 | 0.5219 | 0.5094 |
Echinococcus multilocularis | chromobox protein 1 | 0.0084 | 0.6551 | 0.6461 |
Schistosoma mansoni | jumonji/arid domain-containing protein | 0.0045 | 0.2213 | 0.2999 |
Plasmodium falciparum | phd finger protein, putative | 0.0035 | 0.1138 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0047 | 0.2461 | 0.2714 |
Trichomonas vaginalis | chromobox protein, putative | 0.0051 | 0.2857 | 0.3419 |
Echinococcus multilocularis | Transcription factor, JmjC domain containing protein | 0.0115 | 1 | 1 |
Echinococcus granulosus | chromobox protein 1 | 0.0084 | 0.6551 | 0.6461 |
Schistosoma mansoni | hypothetical protein | 0.0035 | 0.1138 | 0.1543 |
Brugia malayi | Bromodomain containing protein | 0.0046 | 0.236 | 0.1897 |
Brugia malayi | jmjC domain containing protein | 0.0045 | 0.2213 | 0.1741 |
Loa Loa (eye worm) | PHD-finger family protein | 0.0035 | 0.1138 | 0.1701 |
Echinococcus multilocularis | lysine specific demethylase 5A | 0.0043 | 0.1958 | 0.1747 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 0.6551 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0049 | 0.2686 | 0.4014 |
Trichomonas vaginalis | chromobox protein, putative | 0.0084 | 0.6551 | 1 |
Onchocerca volvulus | Heterochromatin protein 1 homolog | 0.0047 | 0.2461 | 0.7695 |
Brugia malayi | Bromodomain containing protein | 0.0038 | 0.1455 | 0.0937 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 3.5481 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 8.9125 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | 10.4179 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of JMJD2A-Tudor Domain. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504402] | ChEMBL. | No reference |
Potency (functional) | 11.2202 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 23.0999 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of RanGTP induced Rango (Ran-regulated importin-beta cargo) - Importin beta complex dissociation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540262] | ChEMBL. | No reference |
Potency (functional) | 56.2341 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 125.8925 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | ||
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.